Literature DB >> 31274044

Identifying an effective mobile health application for the self-management of allergic rhinitis and asthma in Australia.

Rachel Tan1, Biljana Cvetkovski1, Vicky Kritikos1,2, Robyn E O'Hehir3,4, Olga Lourenço5,6, Jean Bousquet7, Sinthia Bosnic-Anticevich1,8.   

Abstract

Objective: People with allergic rhinitis (AR) often self-manage in the community pharmacy setting without consulting health care professionals and trivialize their comorbidities such as asthma. A mobile health application (mHealth app) with a self-monitoring and medication adherence system can assist with the appropriate self-management of AR and asthma. This study aimed to identify an app effective for the self-management of AR and/or asthma.
Methods: MHealth apps retrieved from the Australian Apple App Store and Android Google Play Store were included in this study if they were developed for self-management of AR and/or asthma; in English language; free of charge for the full version; and accessible to users of the mHealth app. The mHealth app quality was evaluated on three domains using a two-stage process. In Stage 1, the apps were ranked along Domain 1 (Accessibility in both app stores). In Stage 2, the apps with Stage 1, maximum score were ranked along Domain 2 (alignment with theoretical principles of the self-management of AR and/or asthma) and Domain 3 (usability of the mHealth app using Mobile App Rating Scale instrument).
Results: Of the 418 apps retrieved, 31 were evaluated in Stage 1 and 16 in Stage 2. The MASK-air achieved the highest mean rank and covered all self-management principles except the doctor's appointment reminder and scored a total MARS mean score of 0.91/1.Conclusions: MASK-air is ranked most highly across the assessment domains for the self-management of both AR and coexisting asthma. This mHealth app covers the majority of the self-management principles and is highly engaging.

Entities:  

Keywords:  Allergic rhinitis; asthma; health care professionals; mobile health applications; self-management; suboptimal management

Mesh:

Year:  2019        PMID: 31274044     DOI: 10.1080/02770903.2019.1640728

Source DB:  PubMed          Journal:  J Asthma        ISSN: 0277-0903            Impact factor:   2.515


  6 in total

Review 1.  Aligning the Good Practice MASK With the Objectives of the European Innovation Partnership on Active and Healthy Ageing.

Authors:  J Bousquet; J Farrell; M Illario
Journal:  Allergy Asthma Immunol Res       Date:  2020-03       Impact factor: 5.764

2.  Functionality and Quality of Asthma mHealth Apps and Their Consistency With International Guidelines: Protocol for a Systematic Search and Evaluation of Mobile Apps.

Authors:  Billy Robinson; Enying Gong; Brian Oldenburg; Katharine See
Journal:  JMIR Res Protoc       Date:  2022-02-09

Review 3.  mHealth and telemedicine utility in the monitoring of allergic diseases.

Authors:  Violeta Kvedarienė; Paulina Burzdikaitė; Inga Česnavičiūtė
Journal:  Front Allergy       Date:  2022-09-02

4.  Applicability of the MASK-Air® App to Severe Asthma Treated with Biologic Molecules: A Pilot Study.

Authors:  Alida Benfante; Bernardo Sousa-Pinto; Gianluca Pillitteri; Salvatore Battaglia; Joao Fonseca; Jean Bousquet; Nicola Scichilone
Journal:  Int J Mol Sci       Date:  2022-09-29       Impact factor: 6.208

5.  SERIES: eHealth in primary care. Part 2: Exploring the ethical implications of its application in primary care practice.

Authors:  Sarah N Boers; Karin R Jongsma; Federica Lucivero; Jiska Aardoom; Frederike L Büchner; Martine de Vries; Persijn Honkoop; Elisa J F Houwink; Marise J Kasteleyn; Eline Meijer; Hilary Pinnock; Martina Teichert; Paul van der Boog; Sanne van Luenen; Rianne M J J van der Kleij; Niels H Chavannes
Journal:  Eur J Gen Pract       Date:  2019-10-30       Impact factor: 1.904

Review 6.  Using Telemedicine to Care for the Asthma Patient.

Authors:  Yudy K Persaud
Journal:  Curr Allergy Asthma Rep       Date:  2022-02-02       Impact factor: 4.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.